Latest News

SUNOVION PHARMACEUTICALS INC: Sunovion and Psychogenics Initiate Diamond Phase 3 Clinical Studies for SEP-363868 in the treatment of Adults and Adolescents with Schizophrenia

Sunovion Pharmaceuticals Inc. (Sunovion) and PsychoGenics Inc. (PsychoGenics), today announced the initiation of the DIAMOND (Developing Innovative Approaches for Mental Disorders) Phase 3 studies for SEP-363856, a novel agent for the treatment of adults and adolescents with schizophrenia.

EMD SERONO, INC: EMD Serono Initiates Pivotal Phase III Program for Investigational Evobrutinib in Relapsing Multiple Sclerosis

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the initiation of two global pivotal Phase III trials (EVOLUTION RMS 1 and 2) studying the efficacy and safety of evobrutinib, an oral, highly selective Bruton's Tyrosine Kinase (BTK) inhibitor in adult patients with relapsing multiple sclerosis (RMS).

BLUEBIRD BIO, INC.: bluebird bio to Present New Data from Clinical Studies of LentiGlobin™ Gene Therapy for Transfusion-Dependent β-thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Congress

bluebird bio, Inc. (Nasdaq: BLUE) announced today that new data from its investigational gene therapy programs for transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) will be presented during the 24th European Hematology Association (EHA) Congress in Amsterdam, the Netherlands, June 13-16.

ACQUIA: Acquia Unveils New Compliance, Security Capabilities for Acquia Cloud

Acquia today announced new capabilities for Acquia Cloud, extending the company’s strengths in security innovation and compliance for digital experience platforms. Additions include new tools to manage risk and updated compliance for a pair of key U.S.

EVERSOURCE ENERGY: Eversource Delivers Solar Power to the Grid, Bringing more Carbon-Free Energy to the Commonwealth

Following the construction of 19 new solar facilities across the commonwealth, Eversource is on track to deliver 62 megawatts of carbon-free, renewable energy to Bay State residents and businesses.

ABBOTT LABORATORIES: Abbott Brings its Proven Flu Fighters

Flu season typically peaks in February: Abbott's technologies are ready to fight back.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Participates in FDA General Issues Panel on Transvaginal Surgical Mesh for Pelvic Organ Prolapse

On February 12, 2019, the U.S. Food and Drug Administration (FDA) convened an advisory panel of experts to discuss the safety and effectiveness of surgical mesh placed transvaginally to treat pelvic organ prolapse (POP).

BOSTON SCIENTIFIC CORPORATION: VICI VENOUS STENT® System Demonstrates Positive Clinical Outcomes in Patients with Deep Venous Blockages

Today, Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions.

ADVANCED MEDICAL STRATEGIES: Treatment for Rare Blood Clotting Disorder Shows Efficacy in Phase 3 Study

New phase 3 data showed positive results for caplacizumab (Cablivi) in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, according to a study published in the New England Journal of Medicine.

ADVANCED MEDICAL STRATEGIES: Massachusetts Initiative Looks at Payment Plans for Novartis’ SMA Gene Therapy

Many of the new biologic drugs and gene therapies coming on the market have shockingly high prices.

ADVANCED MEDICAL STRATEGIES: FDA Creating Innovation Office to Speed Drug Development

The FDA is creating an office of drug development science to cut the cost of bringing new medicines to patients, BioCentury reports.

CENTAGE: How to Forecast Cash Flow

Businesses talk a lot about budgets, revenue projections, and actuals.

CAPE COD CANAL REGION CHAMBER OF COMMERCE: Mass. Coalition for Sustainable Energy

The Massachusetts Coalition for Sustainable Energy (MCSE) continues to add members.

ADVANCED MEDICAL STRATEGIES: Australian Researchers Develop 10-Minute Cancer Test

Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study.

AQUEDUCT TECHNOLOGIES: Aqueduct Earns Cisco Master Data Center and Hybrid Cloud Specialization

Aqueduct Technologies Inc. announced that it has met all requirements to achieve the Cisco® Master Data Center and Hybrid Cloud Specialization.

Metro Business Network